Chronic HIV infection induces significant changes in the trafficking of circulating endothelial progenitor cells (EPCs). Specifically, it causes marked depletion of proangiogenic hematopoietic cells, the so-called colony-forming unit-endothelial cells (CFU-ECs). In this study we evaluated CFU-ECs in two subjects with acute HIV infection. We found that both patients already had a low CFU-EC level at the time of diagnosis. Nevertheless, after 6 months of antiretroviral therapy, the CFU-EC concentration reverted to normal values in both cases. HIV significantly depletes the CFU-EC compartment even in the early phase of infection, while 6-month therapy appears to be able to restore it.
Get full access to this article
View all access options for this article.
References
1.
AsaharaT, MuroharaT, SullivanA, SilverM, van der ZeeR, LiTet al.Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997; 275:964–967.
2.
AntonioN, FernandesR, Rodriguez-LosadaN, Jimenez-NavarroMF, PaivaA, de Teresa GalvanEet al.Stimulation of endothelial progenitor cells: A new putative effect of several cardiovascular drugs. Eur J Clin Pharmacol, 2010; 66:219–230.
3.
MasiaM, PadillaS, GarciaN, JarrinI, BernalE, LopezNet al.Endothelial function is impaired in HIV-infected patients with lipodystrophy. Antivir Ther, 2010; 15:101–110.
BellSK, LittleSJ, RosenbergES. Clinical management of acute HIV infection: Best practice remains unknown. J Infect Dis, 2010; 202,Suppl 2:S278–288.
11.
IngramDA, MeadLE, TanakaH, MeadeV, FenoglioA, MortellKet al.Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 2004; 104:2752–2760.
12.
CostiniukCT, HibbertBM, FilionLG, KovacsCM, BenkoE, O'BrienERet al.Circulating endothelial progenitor cell levels are not reduced in HIV-infected men. J Infect Dis, 2012; 205:713–717.
13.
PapasavvasE, HsueP, ReynoldsG, PistilliM, HancockA, MartinJNet al.Increased CD34(+)/KDR(+) cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects. Antivir Ther, 2012; 17:557–563.
14.
da SilvaEF, FonsecaFA, FrancaCN, FerreiraPR, IzarMC, SalomaoRet al.Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy. AIDS, 2011; 25:1595–1601.
15.
LopezM, VispoE, RomanJS, HerreroD, PerisA, CorralAet al.High risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells. AIDS Res Hum Retroviruses, 2012; 28:656–659.
16.
KojimaY, KawahataT, MoriH. Cases of HIV type 1 acute infection at STI-related clinics in Osaka. AIDS Res Hum Retroviruses, 2009; 25:717–719.
17.
ThompsonMA, AbergJA, CahnP, MontanerJS, RizzardiniG, TelentiAet al.Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA, 2010; 304:321–333.
18.
AnP, BleiberG, DuggalP, NelsonG, MayM, MangeatBet al.APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol, 2004; 78:11070–11076.
19.
FalascaK, UcciferriC, ManzoliL, MancinoP, PizzigalloE, ContiPet al.Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. Int J Immunopathol Pharmacol, 2007; 20:519–527.
20.
FalascaK, UcciferriC, MancinoP, Di IorioA, VignaleF, PizzigalloEet al.Cystatin C, adipokines and cardiovascular risk in HIV infected patients. Curr HIV Res, 2010; 8:405–410.
